Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy. (Q47801764)

5 February 2018

title

Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy. (English)

1 reference

5 February 2018

1 reference

1 reference

F Bozzetti

1

1 reference

5 February 2018

publication date

1 September 2017

1 reference

5 February 2018

published in

Annals of Oncology

1 reference

5 February 2018

volume

28

1 reference

5 February 2018

page(s)

2107-2118

1 reference

5 February 2018

issue

9

1 reference

5 February 2018

Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

The early discontinuation of palliative chemotherapy in older patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Undernutrition as independent predictor of early mortality in elderly cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

The nutritional risk in oncology: a study of 1,453 cancer outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Weight loss in cancer patients: a plea for a better awareness of the issue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Skeletal muscle fiber size and fiber type distribution in human cancer: Effects of weight loss and relationship to physical function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Six-year longitudinal changes in body composition of middle-aged and elderly Japanese: age and sex differences in appendicular skeletal muscle mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Prevalence of sarcopenia in older patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

The association of nutritional assessment criteria with health-related quality of life in patients with advanced colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Comparing two classifications of cancer cachexia and their association with survival in patients with unresected pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Does Sarcopenia Impact Complications and Overall Survival in Patients Undergoing Radical Nephrectomy for Stage III and IV Kidney Cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With Sunitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Prognostic Significance of Sarcopenia in Patients with Metastatic Renal Cell Carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia as a predictor of complications and survival following radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia Adversely Impacts Postoperative Clinical Outcomes Following Gastrectomy in Patients with Gastric Cancer: A Prospective Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia as a predictor of complications in penile cancer patients undergoing inguinal lymph node dissection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Body composition and survival in the early clinical trials setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Relationships between body composition parameters and fluorouracil pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Can body composition be used to optimize the dose of platinum chemotherapy in lung cancer? A feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Effect of body composition on outcomes after hepatic resection for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia as a prognostic factor among patients with stage III melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Worsening central sarcopenia and increasing intra-abdominal fat correlate with decreased survival in patients with adrenocortical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

The Effects of Dietary Omega-3s on Muscle Composition and Quality in Older Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Effects of supplemental fish oil on resting metabolic rate, body composition, and salivary cortisol in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Omega-3 Fatty Acid Supplementation for 12 Weeks Increases Resting and Exercise Metabolic Rate in Healthy Community-Dwelling Older Females

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Fish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Immunonutrition improves functional capacities in head and neck and esophageal cancer patients undergoing radiochemotherapy: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Omega-3 supplements for patients in chemotherapy and/or radiotherapy: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Fish oil supplementation during chemotherapy increases posterior time to tumor progression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Amino acid metabolism and inflammatory burden in ovarian cancer patients undergoing intense oncological therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Nutritional/metabolic response in older cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Is the intravenous supplementation of amino acid to cancer patients adequate? A critical appraisal of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Toward a cancer-specific diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Muscle full effect after oral protein: time-dependent concordance and discordance between human muscle protein synthesis and mTORC1 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Are there any benefits of exercise training in cancer cachexia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Resistance exercise interventions during and following cancer treatment: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Effect of physical exercise on muscle mass and strength in cancer patients during treatment--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Feasibility of exercise during treatment for multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Evidence base for multimodal therapy in cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Early palliative care for patients with metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Cancer Rehabilitation: An Overview of Current Need, Delivery Models, and Levels of Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

The oncologist as coordinator of the nutritional approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia as a Prognostic Index of Nutritional Status in Concurrent Cirrhosis and Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

Prevalence and risk factors of malnutrition among cancer patients according to tumor location and stage in the National Cancer Center in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX271

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDX271

1 reference

5 February 2018

PubMed ID

28911059

1 reference

5 February 2018